This is a limited company view. Sign up for a Free Trial to see everything.

Lycera aims to develop the next generation of drugs able to bring original solutions to patients with the greatest need.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Ann Arbor

Founded

Employees

58

Stage

Series A

Total funding

$41M

Last funding

4 years ago

Acquisitions

0

Growth score

59

Mindshare score

31

Scoring

Deals

$5.0M Debt

Oct 21, 2013

Employee Growth

Use Lycera's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Lycera's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Chief Financial Officer
Executive Director
Associate Director or Biology
Senior Director of CMC
Executive Director of Chemistry
Senior Vice President - Preclinical Development
Senior Office Administrator
Senior Principal Scientist
In Vivo Pharmacologist
Senior Principal Scientist
Senior Scientist
Chief Medical Officer
Senior Principal Scientist
metre
Senior Research Scientist
Senior Research Scientist
Global Controller
Chief Operating Officer
Senior Research Scientist

Similar Companies

Prexa Pharmaceuticals

Prexa Pharmaceuticals develops small molecule monoamine reuptake inhibitors as a treatment for ADHD, depression and Parkinson’s disease.
Series B

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes